CANSORTIUM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.16 USD | 0.00% |
|
-11.11% | +77.78% |
| Jan. 22 | Cansortium Inc. Opens 34th Medical Cannabis Dispensary in Cocoa, Florida | CI |
| 2023 | Cansortium Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Financials (USD)
| Sales 2023 * | 95M | Sales 2024 * | 119M | Capitalization | 47.92M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 0.5 x |
| Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.4 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 60.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cansortium Inc.
More press releases
| 1 week | -11.11% | ||
| Current month | -23.81% | ||
| 1 month | -23.81% | ||
| 3 months | +10.34% | ||
| 6 months | +68.42% | ||
| Current year | +77.78% |
1 week
0.16
0.19
1 month
0.160.25
Current year
0.090.28
1 year
0.060.28
3 years
0.061.20
5 years
0.001.99
10 years
0.002.20
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Beasley
CEO | Chief Executive Officer | - | 20-09-28 |
Henry Batievsky
FOU | Founder | - | 18-08-30 |
Jeffrey Batliner
DFI | Director of Finance/CFO | 58 | 23-03-13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Roger Daher
BRD | Director/Board Member | 58 | 20-04-06 |
Henry Batievsky
FOU | Founder | - | 18-08-30 |
Robert Beasley
CEO | Chief Executive Officer | - | 20-09-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.16 | 0.00% | 137,815 |
| 24-04-25 | 0.16 | -11.11% | 78,412 |
| 24-04-24 | 0.18 | 0.00% | 87,100 |
| 24-04-23 | 0.18 | -2.70% | 189,531 |
| 24-04-22 | 0.185 | +2.78% | 26,000 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 03:59 pm EDT
More quotes
Cansortium Inc. is a vertically integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the private label, Fluent. The Company, through its subsidiaries, is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The Companyâs medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges and edibles and accessories. The Companyâs subsidiaries include Cansortium Holdings LLC, Cansortium Pennsylvania, LLC, Cansortium Puerto Rico, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Fluent Servicing, LLC, Cansortium Florida, LLC., Spirit Lake Road Nursery, LLC, Harvest Park Lot 9 Investors LLC, Fluent Hemp LLC and Cansortium Michigan LLC.
Calendar
2024-04-29
- Q4 2023 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.16
USD
Average target price
0.7
USD
Spread / Average Target
+337.50%
| 1st Jan change | Capi. | |
|---|---|---|
| +77.78% | 47.92M | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -42.17% | 119M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- TIUM.U Stock
